Latest Research | Long Covid
Latest long COVID research explores persistent symptoms, underlying mechanisms, and potential treatments. Studies reveal multi-system impacts, including cardiovascular, neurological, and respiratory issues. Researchers are investigating biomarkers for diagnosis and effective therapeutic interventions. Emerging data suggest the importance of vaccination in reducing long COVID risk. Ongoing trials aim to identify targeted therapies to alleviate prolonged symptoms and improve patient outcomes.
ME/CFS can develop in Long Covid survivors, characterized by severe fatigue, post-exertional malaise, cognitive impairments, and sleep disturbances. Anyone, but predominantly women, can be affected. Management includes pacing, symptom-specific treatments, and multidisciplinary support.
3rd Symposium of Long COVID in Canada 2025
Insights into OMF’s Research Portfolio” Webinar on Thursday 30th October 2025 @ 1300PT/1600ET
A Day in the Life of a Longhauler”, a photo-based project that aims to highlight the daily realities of those living with Long COVID symptoms. This project is made possible via researchers at Simon Fraser University, in partnership with the Museum of Vancouver (MoV) and the PHSA Post-COVID-19 Interdisciplinary Clinical Care Network (PCICCN)].
We're delving into the often overlooked world of long Covid and post-viral syndromes. Ever wondered why the medical community wasn't fully prepared for the enduring effects of post-viral conditions despite its potential impact?
A Day in the Life of a Longhauler”, a photo-based project that aims to highlight the daily realities of those living with Long COVID symptoms. This project is made possible via researchers at Simon Fraser University, in partnership with the Museum of Vancouver (MoV) and the PHSA Post-COVID-19 Interdisciplinary Clinical Care Network (PCICCN)].
E28 Join Professor David Petrino as he delves into groundbreaking long COVID treatments, including repurposed HIV antivirals, patient phenotyping, and the innovative Cohen Center's hybrid approach to care and research for chronic illnesses.
Breaking News Prof Todd Davenport Edits the January edition of CPTJ Dedicated to Long COVID Rehabilitation
PROFESSOR KLIMAS HAS FDA APPROVAL FOR MONOCLONAL ANTIBODY RESEARCH!
E27: Dr. David Putrino discusses the hormonal and neurological impacts of Long COVID, highlighting key research findings, symptom patterns, and emerging treatments through innovative therapies and clinical trials.
